In situ functional dissection of RNA cis-regulatory elements by multiplex CRISPR-Cas9 genome engineering by Wu, Q, Ferry, Q, Baeumler, T, Michaels, Y, Vitsios, D, Habib, O, Arnold, R, Jiang, X, Maio, S, Steinkraus, B, Tapia, M, Piazza, P, Xu, N, Holländer, G, Milne, T, Kim, J, Enright, A, Bassett, A, Fulga, T

Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities by Loesch, DP, Garg, M, Matelska, D, Vitsios, D, Jiang, X, Ritchie, SC, Sun, BB, Runz, H, Whelan, CD, Holman, RR, Mentz, RJ, Moura, FA, Wiviott, SD, Sabatine, MS, Udler, MS, Gause-Nilsson, IA, Petrovski, S, Oscarsson, J, Nag, A, Paul, DS, Inouye, M

Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes by Nag, A, Dhindsa, RS, Mitchell, J, Vasavda, C, Harper, AR, Vitsios, D, Ahnmark, A, Bilican, B, Madeyski-Bengtson, K, Zarrouki, B, Zoghbi, AW, Wang, Q, Smith, KR, Alegre-Díaz, J, Kuri-Morales, P, Berumen, J, Tapia-Conyer, R, Emberson, J, Torres, JM, Collins, R, Smith, DM, Challis, B, Paul, DS, Bohlooly-Y, M, Snowden, M, Baker, D, Fritsche-Danielson, R, Pangalos, MN, Petrovski, S